Background: Chimeric antigen receptor (CAR) T cell therapy directed against cluster of differentiation (CD) 19 is a new promising therapeutic approach in autoimmune diseases. Objectives: To evaluate ...

Objective: To evaluate the existing evidence on the diagnosis and management of septic arthritis in native joints. Design: Systematic review. Data sources: Cochrane Library, Medline, Embase, National ...

OBJECTIVE To determine the efficacy of the individual components of physiotherapy in subjects with anterior knee pain. METHODS An observer blind, prospective, factorial design randomised controlled ...

OBJECTIVE To study the prevalence of ultrasonic hip joint effusion and its relation with clinical, radiological and laboratory (ESR) findings in adults with hip pain. METHODS Patients (n=224) aged 50 ...

Background: Fatigue is an important outcome for patients with rheumatoid arthritis (RA). As recommended by the European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) task ...

Objectives To update the 2017 European Alliance of Associations for Rheumatology (EULAR) recommendations for treatment of systemic sclerosis (SSc), incorporating new evidence and therapies. Methods An ...

Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III ...

We read with great interest the recent paper by Aranow et al 1 about the impact of laboratory results on scoring of the Physician Global Assessment (PGA) of disease activity in systemic lupus ...

Objectives The usefulness of methotrexate-polyglutamates (MTX-PGs) concentration for management of rheumatoid arthritis has been debated. We aimed to clarify the association of MTX-PGs concentration ...

We have enjoyed reading the ‘Heroes and Pillars of Rheumatology’ section of Ann Rheum Dis which was introduced in 2018 to highlight ‘persons or scientific innovations of the past that were pivotal in ...

We read the paper by Rimar et al 1 in your journal with great interest. They reported the case with refractory polyarteritis nodosa treated with tofacitinib, a janus kinase inhibitor, successfully. As ...

We read with interest the paper by Aranow et al 1 where physician’s global assessment (PGA) displayed excellent inter-rater reliability, which could rely on the inclusion of highly selected lupus ...